Skip to main content
Caplight Logo









Nunaps

Nunaps

Private
SeoulHealthcare & Life Scienceshttps://www.nunaps.com/

Last Round

Series B

Jan 1, 2025

Total Funding Raised

$13.47M

Company Overview

Nunaps is a digital therapeutics company that develops software-based medical devices and platforms to treat and manage neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital therapeuticsDTxsoftware as a medical deviceSaMDvirtual reality therapyneuro-rehabilitationvisual field defectsmedical AIneuroplasticitystroke recoverydigital healthclinical-stage softwarehealthtechvisual perceptual learningneurological disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nunaps Comparables

Compare Nunaps with similar companies based on industry and business-model similarity.

Nunaps comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emocog
78%
HAII
76%
Incline Equity Partners
74%

Nunaps Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 1, 2025
Series AJan 5, 2020
SeedDec 1, 2017

Nunaps Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Grew 200% QoQ, from 2 to 6 employees.

  • Mar 14, 2026

    Grew 500% QoQ from 1 to 6 employees.

Nunaps Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nunaps Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nunaps's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range7
Year Founded2017
Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?